Prostaglandin production by melanocytic cells and the effect of a-melanocyte stimulating hormone
dc.contributor.author | Nicolaou, Anna | * |
dc.contributor.author | Estdale, Siân E. | * |
dc.contributor.author | Tsatmali, Marina | * |
dc.contributor.author | Herrero, Daniel Pascual | * |
dc.contributor.author | Thody, Anthony J. | * |
dc.date.accessioned | 2009-12-15T11:02:42Z | |
dc.date.available | 2009-12-15T11:02:42Z | |
dc.date.issued | 2004 | |
dc.identifier.citation | Nicolaou A, Estdale SE, Tsatmali M, Herrero DP and Thody AJ (2004). Prostaglandin production by melanocytic cells and the effect of melanocyte stimulating hormone. FEBS Letters. 570(1-3): 223-226. | en |
dc.identifier.uri | http://hdl.handle.net/10454/4098 | |
dc.description | No | en |
dc.description.abstract | Prostaglandins are potent mediators of the inflam-matory response and are also involved in cancer development. In this study, we show that human melanocytes and FM55 melanoma cells express cyclooxygenase-1 and -2 (COX-1 and-2) and thus have the capability to produce prostaglandins. TheFM55 cells produced predominantly PGE2and PGF2a, whereas the HaCaT keratinocyte cell line produced mainly PGE2. The anti-inflammatory peptide, a-melanocyte stimulating hormone(a-MSH), reduced prostaglandin production in FM55 and HaCaT cells and reversed the effect of the pro-inflammatory cytokine TNF-a in the former. These results indicate that melanocytes produce prostaglandins and that a-MSH, by inhibiting this response, may play an important role in regulating inflammatory responses in the skin. | en |
dc.language.iso | en | en |
dc.relation.isreferencedby | http://dx.doi.org/10.1016/j.febslet.2004.06.041 | en |
dc.subject | Prostaglandin; FM55; Melanocytic Cell; Cyclooxygenase; HaCaT; a-Melanocyte Stimulating Hormone | en |
dc.title | Prostaglandin production by melanocytic cells and the effect of a-melanocyte stimulating hormone | en |
dc.status.refereed | Yes | en |
dc.type | Article | en |
dc.type.version | No full-text available in the repository | en |